42 Stocks Moving In Monday’s Mid-Day Session
Gainers
Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.
CORRECTION: Reata Pharmaceuticals Q4 EPS $(1.59) Beats $(2.31) Estimate, Sales $934.00K Miss $1.63M Estimate
Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(2.31) by 31.17 percent. This is a 27.2 percent decrease over losses of $(1.25) per share
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the holiday-shortened week before making a comeback.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
45 Biggest Movers From Yesterday
Gainers
ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55.